Research & Development
ATS, IDSA revamp pneumonia testing guidance
The new recommendations apply to the diagnosis and treatment of community-acquired pneumonia, from the time of signs and symptoms through treatment with antibiotics and follow-up chest imaging. They were published by a multidisciplinary team, including Dr. Joshua Metlay, PhD, chief of internal medicine at Massachusetts General Hospital (American Journal of Respiratory and Critical Care Medicine, October 1, 2019, Vol. 200:7, pp. e45-e65).
October 2, 2019
Coated, folded paper creates mobile lab for field tests
The coated paper worked significantly more efficiently and reliably than any type of dry, uncoated paper when testing biological materials in the field -- for example, for use following a natural disaster, wrote Daniel Regan, a research and development engineer at the University of Maine, and colleagues in the journal, a publication of the American Institute of Physics.
August 20, 2019
iCubate's iC-GN Gram-negative assay clears FDA
Bacteria picked up by the iC-GN test include Acinetobacter baumannii complex, Escherichia coli, and Klebsiella pneumoniae, while the antibiotic resistance markers screened by the test include K. pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM). Testing takes from two to three minutes, with results available in from 3 to 4.5 hours, according to the company.
July 14, 2019
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Page 1 of 1